| [1] |
Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.
Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer
[J]. Journal of International Oncology, 2024, 51(6): 321-325.
|
| [2] |
Yuan Jian, Huang Yanhua.
Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer
[J]. Journal of International Oncology, 2024, 51(6): 338-343.
|
| [3] |
Wang Ying, Liu Nan, Guo Bing.
Advances of antibody-drug conjugate in the therapy of metastatic breast cancer
[J]. Journal of International Oncology, 2024, 51(6): 364-369.
|
| [4] |
Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.
Study on the clinical relationship between inflammatory burden index and gastric cancer
[J]. Journal of International Oncology, 2024, 51(5): 274-279.
|
| [5] |
Sa Qiang, Xu Hangcheng, Wang Jiayu.
Advances in immunotherapy for breast cancer
[J]. Journal of International Oncology, 2024, 51(4): 227-234.
|
| [6] |
Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong.
Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer
[J]. Journal of International Oncology, 2024, 51(4): 235-238.
|
| [7] |
Xie Shuping, Sun Yahong, Wang Chao.
Prediction of efficacy of early-stage tumor markers combined with NLR and PLR for immunotherapy in gastric cancer
[J]. Journal of International Oncology, 2024, 51(3): 157-165.
|
| [8] |
Liu Yulan, Jing Haiyan, Sun Jing, Song Wei, Sha Dan.
Advances in predicting efficacy and prognostic markers of immunotherapy for gastric cancer
[J]. Journal of International Oncology, 2024, 51(3): 175-180.
|
| [9] |
Chen Boguang, Wang Sugui, Zhang Yongjie.
Role of serum cholinesterase and inflammatory markers in the prognosis of stage ⅠA -ⅢA breast cancer
[J]. Journal of International Oncology, 2024, 51(2): 73-82.
|
| [10] |
He Jiahui, Hu Qinyong.
Comparative analysis of lung cancer incidence and mortality trends and risk factors in China and the United States based on GBD data
[J]. Journal of International Oncology, 2024, 51(1): 29-36.
|
| [11] |
Gu Huayan, Zhu Teng, Guo Guilong.
Breast microbiota and breast cancer： present and future
[J]. Journal of International Oncology, 2024, 51(1): 55-58.
|
| [12] |
Wang Jing, Xu Wenting.
Value of NLR， CEA combined with coagulation indicators in the differential diagnosis of benign and malignant breast nodules with a diameter ≤ 1.0 cm
[J]. Journal of International Oncology, 2023, 50(9): 520-526.
|
| [13] |
Feng Chengtian, Huang Furong, Cao Shiyu, Wang Jianyu, Nanding Abiyasi, Jiang Yongdong, Zhu Juanying.
Relationships between HER2 protein expression and imaging features in HER2 positive breast cancer patients
[J]. Journal of International Oncology, 2023, 50(9): 527-531.
|
| [14] |
Feng Dongxu, Wu Wei, Gao Pingfa, Wang Jun, Shi Lijuan, Chen Dawei, Li Wenbing, Zhang Meifeng.
Effects of miR-451 on glycolysis and apoptosis of breast cancer cells by regulating Rho/ROCK1 pathway
[J]. Journal of International Oncology, 2023, 50(8): 449-456.
|
| [15] |
Pan Shulan, Liu Chang, He Ping.
Effect of fritinib on angiogenesis, tumor growth and IRE1-ASK1-JNK pathway in triple negative breast cancer
[J]. Journal of International Oncology, 2023, 50(8): 457-462.
|
